73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
{{items.name}}
α-KG-dependent glycolysis activation by BCAT1 contributes to EGFR-TKI resistance in NSCLC
Oncology
α-KG-dependent glycolysis activation by BCAT1 contributes to EGFR-TKI resistance in NSCLC
November 28,2024
Latest Articles
Investigators explore impact of cigarette smoking and alcohol consumption on Black breast cancer survivors

Investigators explore impact of cigarette smoking and alcohol consumption on Black breast cancer survivors

by Rutgers Cancer Institute of New JerseyCredit: Unsplash/CC0 Public DomainInvestigators from Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehe
Updated on: December 20,2023
Investigators explore impact of cigarette smoking and alcohol consumption on Black breast cancer survivors

Investigators explore impact of cigarette smoking and alcohol consumption on Black breast cancer survivors

by Rutgers Cancer Institute of New JerseyCredit: Unsplash/CC0 Public DomainInvestigators from Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehe
Updated on:December 20,2023
New algorithm detects even the smallest cancer metastases across the entire mouse body

New algorithm detects even the smallest cancer metastases across the entire mouse body

byHelmholtz Association of German Research CentresDeepMACT makes use of artificial intelligence to find even the smallest metastases in the entire mouse body. The picture shows single disseminat
Updated on: December 23,2023
New algorithm detects even the smallest cancer metastases across the entire mouse body

New algorithm detects even the smallest cancer metastases across the entire mouse body

byHelmholtz Association of German Research CentresDeepMACT makes use of artificial intelligence to find even the smallest metastases in the entire mouse body. The picture shows single disseminat
Updated on:December 23,2023
Protein movement reveals brain tumor's weak spot

Protein movement reveals brain tumor's weak spot

by Annika Lund,Karolinska InstitutetCredit: Unsplash/CC0 Public DomainProteins do not have a single shape, but are more like dynamic robots. But—how do they actually move? And what does this tel
Updated on: December 20,2023
Protein movement reveals brain tumor's weak spot

Protein movement reveals brain tumor's weak spot

by Annika Lund,Karolinska InstitutetCredit: Unsplash/CC0 Public DomainProteins do not have a single shape, but are more like dynamic robots. But—how do they actually move? And what does this tel
Updated on:December 20,2023
New study categorizes and examines four different types of model related to cancerous tumors

New study categorizes and examines four different types of model related to cancerous tumors

by John Stevenson,City University LondonCategories of model and PubMed entries. Credit: Dr Constantino Carlos Reyes AldasoroThe term model is employed quite widely in science and technology.Rese
Updated on: January 07,2024
New study categorizes and examines four different types of model related to cancerous tumors

New study categorizes and examines four different types of model related to cancerous tumors

by John Stevenson,City University LondonCategories of model and PubMed entries. Credit: Dr Constantino Carlos Reyes AldasoroThe term model is employed quite widely in science and technology.Rese
Updated on:January 07,2024
Guideline updated for initial management of advanced prostate cancer

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri
Updated on: January 08,2024
Guideline updated for initial management of advanced prostate cancer

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri
Updated on:January 08,2024
A new role for a triple-negative breast cancer target

A new role for a triple-negative breast cancer target

by Katherine Unger Baillie,University of PennsylvaniaLed by Penn Vet scientists, a new study reveals that the protein deltaNp63, whichfosters the initiation and progression of triple-negat
Updated on: December 22,2023
A new role for a triple-negative breast cancer target

A new role for a triple-negative breast cancer target

by Katherine Unger Baillie,University of PennsylvaniaLed by Penn Vet scientists, a new study reveals that the protein deltaNp63, whichfosters the initiation and progression of triple-negat
Updated on:December 22,2023
Why people with breast cancer should ask their health care team about clinical trials

Why people with breast cancer should ask their health care team about clinical trials

by Deb Balzer,Mayo ClinicCredit: Mayo ClinicTreatments for breast cancer have improved over the years, but much research still needs to be done.That's why Dr. Saranya Chumsri, a Mayo Clinic
Updated on: January 08,2024
Why people with breast cancer should ask their health care team about clinical trials

Why people with breast cancer should ask their health care team about clinical trials

by Deb Balzer,Mayo ClinicCredit: Mayo ClinicTreatments for breast cancer have improved over the years, but much research still needs to be done.That's why Dr. Saranya Chumsri, a Mayo Clinic
Updated on:January 08,2024
Scientists identify a gene signature to assess cancer risk in people

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron
Updated on: December 27,2023
Scientists identify a gene signature to assess cancer risk in people

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron
Updated on:December 27,2023
Gene mutations should be tested routinely for ovarian cancer, say scientists

Gene mutations should be tested routinely for ovarian cancer, say scientists

by Mike Addelman,University of ManchesterCredit: Unsplash/CC0 Public DomainScientists from The University of Manchester have shown that testing for two gene families linked to a lifetime epithel
Updated on: December 27,2023
Gene mutations should be tested routinely for ovarian cancer, say scientists

Gene mutations should be tested routinely for ovarian cancer, say scientists

by Mike Addelman,University of ManchesterCredit: Unsplash/CC0 Public DomainScientists from The University of Manchester have shown that testing for two gene families linked to a lifetime epithel
Updated on:December 27,2023
A potential therapy to reduce the side effects of chemotherapy

A potential therapy to reduce the side effects of chemotherapy

byInstitut National de la Sante et de la Recherche MedicaleGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI152924Cisplatin is a chemotherapy indic
Updated on: December 26,2023
A potential therapy to reduce the side effects of chemotherapy

A potential therapy to reduce the side effects of chemotherapy

byInstitut National de la Sante et de la Recherche MedicaleGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI152924Cisplatin is a chemotherapy indic
Updated on:December 26,2023
Cancer: People living in England's poorest areas at higher risk of death—new study

Cancer: People living in England's poorest areas at higher risk of death—new study

by David Nelson,The ConversationCredit: Pixabay/CC0 Public DomainNationally, the risk of dying from most cancers is falling thanks to improvements inscreening, diagnostics and treatment. B
Updated on: December 30,2023
Cancer: People living in England's poorest areas at higher risk of death—new study

Cancer: People living in England's poorest areas at higher risk of death—new study

by David Nelson,The ConversationCredit: Pixabay/CC0 Public DomainNationally, the risk of dying from most cancers is falling thanks to improvements inscreening, diagnostics and treatment. B
Updated on:December 30,2023
More News
Categories
Allergy&Clinical immunology
Anesthesiology & Pain
Cardiovascular Diseases
Dermatology
Diabetes & Endocrinology
Emergency Medicine & Critical Care
ENT & HN
Family Medicine
Gastroenterology
General Surgery
Geriatrics
Hematology&Oncology
Infectious Diseases
Nephrology & Urology
Neurology
Nutrition
OB & GYN
Ophthalmology
Orthopedics & Sports medicine
Pediatrics
Plastic Surgery
Psychiatry & Mental Health
Public Health & Prevention
Pulmonology
Rheumatology
Stomatology
Sleep
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com